Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 5Myeloid 4Lymphoid 4Gynecologic 4Other hematologic neoplasm 3Thoracic 2CNS 2Plasma cell 1Other neoplasm 1NET 1Genitourinary 1Gastrointestinal 1Endocrine 1

Conditions

Brain Neoplasms 1905Glioblastoma 1797Glioma 1130Central Nervous System Neoplasms 599Astrocytoma 594Neuroblastoma 552Gliosarcoma 465Oligodendroglioma 364Neoplasms 312Breast Neoplasms 273Medulloblastoma 272Carcinoma, Non-Small-Cell Lung 227Recurrence 199Sarcoma 184Neoplasm Metastasis 183Melanoma 182Meningioma 177Ependymoma 176Lung Neoplasms 157Lymphoma 134Osteosarcoma 127Meningeal Carcinomatosis 126Neurofibromatosis 1 114Wilms Tumor 111Ovarian Neoplasms 110Diffuse Intrinsic Pontine Glioma 105Precursor Cell Lymphoblastic Leukemia-Lymphoma 103Rhabdomyosarcoma 101Lymphoma, Non-Hodgkin 96Burkitt Lymphoma 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Hypersensitivity × CNS × Clear all
NCT04700748 2021-01-08

Diffusion-weighted MRI to Predict Treatment Response in Stereotactic Radiotherapy of Central Nervous System (CNS) Metastases

Lund University Hospital

Phase NA Unknown
150 enrolled
CNS

Brain Neoplasms, Hypersensitivity

NCT03739333 2020-02-13

TIGRE

Hospices Civils de Lyon

Phase NA Unknown
40 enrolled
CNS

Glioblastoma, Hypersensitivity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡